Effects of Three Treatment Modes on Plasma Lipids and Lipoproteins in Uraemic Patients

References

• Lindner A, Charra B, Sherrard D J., Scribner B H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697–701
   PubMed Web of Science ®Google Scholar
• Burton B T., Krueger K K., Bryan F A. National registry of long‐term dialysis patients. JAMA 1971; 218: 718–22
   PubMed Web of Science ®Google Scholar
• Tsukamoto Y, Wakabayshi Y, Okubo M, Marumo F. Abnormal profiles at various stages of uraemia. Nephrol Dial Transplant 1989; 4: 142–5
   Google Scholar
• Reade R, Equagoo V, Cachera C, et al. Apolipoprotein B immunochemical heterogeneity in dialysed patients with chronic renal failure and patients with coronary artery stenosis. Am J Nephrol 1989; 9: 110–4
   Google Scholar
• Ohta T, Hattori S, Nishiyama S, Higashi A, Matsuda I. Quantitative and qualitative changes of apolipoprotein Al‐containing lipoproteins in patients on continuous ambulatory peritoneal dialysis. Metabolism 1989; 38: 843–9
   Google Scholar
• Heuck C ‐C, Ritz E. Hyperlipoproteinemia in renal insufficiency. Nephron 1980; 25: 1–7
   PubMedGoogle Scholar
• Chan P CK, Persaud J, Varghese Z, Kingstone D, Baillod R A., Moorhead J F. Apolipoprotein B turnover in dialysis patients: its relationship to pathogenesis of hyperlipidemia. Clin Nephrol 1989; 31: 88–95
   PubMed Web of Science ®Google Scholar
• Nestel P J., Fidge N H., Tan M H. Increased lipoprotein‐remnant formation in chronic renal failure. N Engl J Med 1982; 307: 329–33
   PubMed Web of Science ®Google Scholar
• Attman P ‐O, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia—relation to renal function and dialysis. Nephron 1991; 57: 401–10
   PubMed Web of Science ®Google Scholar
• Aviram M, Lund‐Katz S, Phillips M C., Chait A. The influence of the triglyceride content of the low density lipoprotein on the interaction of apolipoprotein B‐100 with cells. J Biol Chem 1988; 263: 16842–8
   PubMed Web of Science ®Google Scholar
• Hörkkö S, Savolainen M J., Kervinen K, Kesäniemi Y A. Carbamylation‐induced alterations in low‐density lipoprotein metabolism. Kidney Int 1992; 41: 1175–81
   PubMed Web of Science ®Google Scholar
• Hörkkö S, Huttunen K, Kervinen K, Kesäniemi Y A. Decreased clearance of uremic and mildly carbamylated low‐density lipoprotein. Eur J Clin Invest 1994; 24: 105–13
   PubMed Web of Science ®Google Scholar
• Hörkkö S, Huttunen K, Korhonen T, Kesäniemi Y A. Decreased clearance of low‐density lipoprotein in patients with chronic renal failure. Kidney Int 1994; 45: 561–70
   PubMed Web of Science ®Google Scholar
• Shapiro R J. Catabolism of low‐density lipoprotein is altered in experimental chronic renal failure. Metabolism 1993; 42: 162–9
   Google Scholar
• Havel R J., Eder H A., Bragdon J H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
   PubMed Web of Science ®Google Scholar
• Lowry O H., Rosebrough N J., Farr A L., Randall R J. Protein measurements with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Holmquist L, Carlson K. Selective extraction of human serum very low density apolipoproteins with organic solvents. Biochim Biophys Acta 1977; 493: 400–9
   PubMed Web of Science ®Google Scholar
• Lipid Research Clinics Program. Manual of laboratory operations. Lipid and lipoprotein analysis. DHEW publications (NIH) 1974; 1: 75
   Google Scholar
• Ehnholm C, Lukka M, Kuusl T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986; 27: 227–35
   PubMed Web of Science ®Google Scholar
• Menzel H ‐J, Utermann G. Apolipoprotein E phenotyping from serum by western blotting. Electrophoresis 1986; 7: 492–5
   Google Scholar
• Atger V, Duval F, Frommherz K, Drüeke T, Lacour B. Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugatiorv. relative enrichment of HDL in apolipoprotein C‐lll at the expense of apolipoprotein A‐1. Atherosclerosis 1988; 74: 75–83
   PubMed Web of Science ®Google Scholar
• Dleplinger H, Schoenfeld P Y., Fielding C J. Plasma cholesterol metabolism in end‐stage renal disease. J Clin Invest 1986; 77: 1071–83
   Google Scholar
• Aitchison J. The statistical analysis of compositional data. Chapman and Hall, London 1986
   Google Scholar
• Georgopoulos A, Rosengard A M. Abnormalities in the metabolism of postprandial and fasting triglyceride‐rich lipoprotein subfractions in normal and insulin‐dependent diabetic subjects: effects of sex. Metabolism 1989; 38: 781–9
   Google Scholar
• Georgopoulos A, Phair R D. Abnormal clearance of postprandial S, 100–400 plasma lipoproteins in insulin‐dependent diabetes mellitus. J Lipid Res 1991; 32: 1133–41
   Google Scholar
• Aitchison J. CODA: Compositional data analysis program. Chapman and Hall, London 1986
   Google Scholar
• Huttunen J K., Pasternack A, Vänttlnen T, Ehnholm C, Nikkilä E A. Lipoprotein metabolism in patients with chronic uremia. Acta Med Scand 1978; 204: 221–8
   Google Scholar
• Mordasini R, Frey F, Flury W, Klose G, Greten H. Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 1977; 297: 1362–6
   PubMed Web of Science ®Google Scholar
• Murase T, Cattran D C., Rubenstein B, Stelner G. Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism 1975; 24: 1279–86
   PubMed Web of Science ®Google Scholar
• Hulley S B., Rosenman R H., Bawol R D., Brand R J. Epidemiology as a guide to clinical decisions. N Engl J Med 1980; 302: 1383–9
   PubMed Web of Science ®Google Scholar
• Kleinman Y, Eisenberg S, Oschry Y, Gavish D, Stein O, Stein Y. Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. J Clin Invest 1985; 75: 1796–1803
   Google Scholar
• Kleinman Y, Oschry Y, Eisenberg S. Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridemic low density lipoprotein: normalization with bezafibrate therapy. Eur J Clin Invest 1987; 17: 538–43
   Google Scholar
• Kleinman Y, Schonfeld G, Gavish D, Oschry Y, Eisenberg S. Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients. J Lipid Res 1987; 28: 540–8
   Google Scholar
• Brunzell J D., Albers J J., Haas L B., Goldberg A P., Agadoa L, Sherrard D J. Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 1977; 26: 903–10
   PubMed Web of Science ®Google Scholar
• Chan M K. Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high density lipoprotein subfractions. Metabolism 1989; 38: 939–45
   PubMed Web of Science ®Google Scholar
• Hsla S L., Perez G O., Mendez A J., Schiffman J, Fletcher S, Stoudemire J B. Defect in cholesterol transport in patients receiving maintenance hemodialysis. J Lab Clin Med 1985; 106: 53–61
   Google Scholar
• Mendez A J., Perez G O., Hsla S I. Defect in cholesterol ester transport in serum of patients with uremia receiving maintenance hemodialysis: increased inhibitor activity for cholesterol ester transfer. J Lab Clin Med 1988; 111: 677–83
   PubMed Web of Science ®Google Scholar
• Attman P ‐O, Gustafson A. Lipid and carbohydrate metabolism in uraemia. Eur J Clin Invest 1979; 9: 285–91
   Google Scholar
• Feussner G, Wey S, Bommer J, Ziegler R. Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis. Eur J Clin Invest 1991; 12: 34
   Google Scholar
• Feussner G, Way S, Bommer J, Deppermann D, Grützmacher P, Ziegler R. Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis. Hum Genet 1992; 88: 307–12
   PubMed Web of Science ®Google Scholar
• Sniderman A, Cianfloner K, Kwiterovich P O., Hutchinson T, Barre P, Prichard S. Hyperapolipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory perineal dialysis. Atherosclerosis 1987; 65: 257–64
   PubMedGoogle Scholar
• Khanna R, Oreopolos D G. Peritoneal dialysis. Diseases of the kidney, R W. Schries, C W. Gottschalk. Little, Brown and Company, Boston 1993; 2696–3030
   Google Scholar
• Canusa peritoneal dialysis study group. Canada‐USA multicenter of peritoneal ialysis adequacy; description of the study population and preliminary results. Adv Peril Dial 1992; 8: 88–92
   Google Scholar
• Maiorca R, Cancarini G C., Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int 1993; 43: 4–15
   Google Scholar